There is clear evidence in support of Remeste
mcel- L in COVID -19, not so much for Remdesivir.
But the study was a JOINT study - Gilead and National institute of allergy & Infectious diseases( ? Conflict of interest Dr Fauci), 9 members of the US panel who establish treatment guidelines have been reported to have financial interest
in Gilead.
so, Gilead ‘s study trial findings would be
under scrutiny.
There is clear evidence in support of Remestemcel- L in COVID...
-
- There are more pages in this discussion • 16,080 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
-0.035(3.41%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| $1.03 | $1.04 | 96.5¢ | $8.837M | 8.885M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 59782 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 26617 | 2 |
View Market Depth
| Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |